116 related articles for article (PubMed ID: 15483676)
1. Cryptic ins(2;11) with clonal evolution showing amplification of 11q23-q25 either on hsr(11) or on dmin, in a patient with AML-M2.
Vazquez I; Lahortiga I; Agirre X; Larrayoz MJ; Vizmanos JL; Ardanaz MT; Zeleznik-Le NJ; Calasanz MJ; Odero MD
Leukemia; 2004 Dec; 18(12):2041-4. PubMed ID: 15483676
[No Abstract] [Full Text] [Related]
2. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies.
Poppe B; Vandesompele J; Schoch C; Lindvall C; Mrozek K; Bloomfield CD; Beverloo HB; Michaux L; Dastugue N; Herens C; Yigit N; De Paepe A; Hagemeijer A; Speleman F
Blood; 2004 Jan; 103(1):229-35. PubMed ID: 12946992
[TBL] [Abstract][Full Text] [Related]
3. Amplification of the 11q23 region in acute myeloid leukemia.
Avet-Loiseau H; Godon C; Li JY; Daviet A; Mellerin MP; Talmant P; Harousseau JL; Bataille R
Genes Chromosomes Cancer; 1999 Oct; 26(2):166-70. PubMed ID: 10469455
[TBL] [Abstract][Full Text] [Related]
4. Variations in MLL amplification in a patient with acute myeloid leukemia.
Brezinová J; Zemanová Z; Cermák J; Kurková S; Sindelárová L; Schwarz J; Michalová K
Leuk Lymphoma; 2002 Oct; 43(10):2031-5. PubMed ID: 12481904
[TBL] [Abstract][Full Text] [Related]
5. Oncogene amplification in transforming myelodysplasia.
Papenhausen PR; Griffin S; Tepperberg J
Exp Mol Pathol; 2005 Oct; 79(2):168-75. PubMed ID: 16026782
[TBL] [Abstract][Full Text] [Related]
6. MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia.
Fleischman EW; Reshmi S; Frenkel MA; Konovalova WI; Guleva GP; Kulagina OE; Konstantinova LN; Tupitsyn NN; Rowley JD
Genes Chromosomes Cancer; 1999 Feb; 24(2):151-5. PubMed ID: 9885982
[TBL] [Abstract][Full Text] [Related]
7. Acute myelocytic leukemia with t(11;17)(q23;q12-q21) involves a fusion of MLL and AF17.
Moore SD; Strehl S; Dal Cin P
Cancer Genet Cytogenet; 2005 Feb; 157(1):87-9. PubMed ID: 15676155
[No Abstract] [Full Text] [Related]
8. Cryptic 5' MLL gene insertion in an X-chromosome in acute myeloblastic leukemia.
Douet-Guilbert N; Arnaud B; Morel F; Le Bris MJ; De Braekeleer M
Cancer Genet Cytogenet; 2005 Mar; 157(2):178-80. PubMed ID: 15721643
[TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
[TBL] [Abstract][Full Text] [Related]
10. Detection of cryptic MLL insertions using a commercial dual-color fluorescence in situ hybridization probe.
Dyson MJ; Talley PJ; Reilly JT; Stevenson D; Parsons E; Tighe J
Cancer Genet Cytogenet; 2003 Nov; 147(1):81-3. PubMed ID: 14580777
[TBL] [Abstract][Full Text] [Related]
11. Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia.
Fu JF; Hsu JJ; Tang TC; Shih LY
Genes Chromosomes Cancer; 2003 Jun; 37(2):214-9. PubMed ID: 12696071
[TBL] [Abstract][Full Text] [Related]
12. MLL amplification in acute leukaemia: a United Kingdom Cancer Cytogenetics Group (UKCCG) study.
Cuthbert G; Thompson K; McCullough S; Watmore A; Dickinson H; Telford N; Mugneret F; Harrison C; Griffiths M; Bown N
Leukemia; 2000 Nov; 14(11):1885-91. PubMed ID: 11069023
[TBL] [Abstract][Full Text] [Related]
13. A case of infantile acute myelogenous leukemia with MLL-MLL10 fusion caused by insertion of 11q into 10p.
Christiansen L; Allen RA; Dunn ST; Wolff DJ
Cancer Genet Cytogenet; 2005 Jun; 159(2):181-3. PubMed ID: 15899395
[No Abstract] [Full Text] [Related]
14. Distinct sequences on 11q13.5 and 11q23-24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patients.
Zatkova A; Ullmann R; Rouillard JM; Lamb BJ; Kuick R; Hanash SM; Schnittger S; Schoch C; Fonatsch C; Wimmer K
Genes Chromosomes Cancer; 2004 Apr; 39(4):263-76. PubMed ID: 14978788
[TBL] [Abstract][Full Text] [Related]
15. FISH analysis of an AML-M5a with segmental rearrangements involving 11q23-MLL region.
Reddy KS; Parsons L; Wang S; Mak L; Dighe P; Yu TL
Cancer Genet Cytogenet; 2000 Apr; 118(1):48-51. PubMed ID: 10731590
[TBL] [Abstract][Full Text] [Related]
16. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents.
Andersen MK; Christiansen DH; Kirchhoff M; Pedersen-Bjergaard J
Genes Chromosomes Cancer; 2001 May; 31(1):33-41. PubMed ID: 11284033
[TBL] [Abstract][Full Text] [Related]
17. The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia.
De Braekeleer M; Morel F; Le Bris MJ; Herry A; Douet-Guilbert N
Anticancer Res; 2005; 25(3B):1931-44. PubMed ID: 16158928
[TBL] [Abstract][Full Text] [Related]
18. Increased amplification proximal to the MLL gene in acute myeloid leukemia.
Lee AS; Lie DK; Tien SL; Rudduck-Sivaswaren C
Int J Mol Med; 2004 Jan; 13(1):63-7. PubMed ID: 14654972
[TBL] [Abstract][Full Text] [Related]
19. A case of acute myelogenous leukemia: myelodysplastic syndrome with t(2;11)(p21;q23) without MLL rearrangement.
Gozzetti A; Tozzuoli D; Crupi R; Raspadori D; Fabbri A; Lauria F
Cancer Genet Cytogenet; 2003 Jul; 144(2):177-8. PubMed ID: 12850382
[No Abstract] [Full Text] [Related]
20. Homogeneously staining region (hsr) on chromosome 11 is highly specific for KMT2A amplification in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Sakhdari A; Tang Z; Ok CY; Bueso-Ramos CE; Medeiros LJ; Huh YO
Cancer Genet; 2019 Oct; 238():18-22. PubMed ID: 31425921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
